NASDAQ

CytoMed Therapeutics Limited - Ordinary Shares (GDTC)

♥ 585 Thanks from members

Live price chart, market sentiment, and community perspectives for CytoMed Therapeutics Limited (NASDAQ: GDTC).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Ho Kee SoonFounder: Lui Mun HonLeadership: Eric Loh (CEO)Leadership: Ho Kee Soon (CTO)Holder: CytoMed PromotersHolder: Institutional Private InvestorsCYM-201Gamma Delta T Cell TherapyCAR-T Cell Therapeutics#GDTC#CytoMed Therapeutics#Biotech Stocks#Cell Therapy#Cancer Immunotherapy